Ro52,Ro60 and La IgG autoantibody levels and Ro52 IgG subclass profiles longitudinally throughout pregnancy in congenital heart block risk pregnancies

Abstract

Congenital heart block occurs in fetuses of Ro/SSA and La/SSB positive women. To investigate the stability of maternal autoantibody levels during pregnancy, we followed Ro52, Ro60 and La autoantibody IgG level variation and Ro52 subclass profiles longitudinally in selected congenital heart block risk pregnancies. Serum samples were obtained from 12 Ro/La positive women diagnosed with a systemic rheumatic disease and followed on average 60 months (range two to 84) which included 13 pregnancies. Seven children were affected by neonatal lupus, whereof four developed complete congenital heart block. Serum was also collected from the babies at birth. Ro52, Ro60 and La IgG as well as subclass antibodies were analysed by ELISA using recombinant antigens. Six Ro/La negative rheumatic patients were included as controls for antibody levels during pregnancy.

Ro52, Ro60 and La IgG levels decreased progressively from early to late pregnancy, significantly for Ro52 and Ro60 (P < 0.01). No peaks or persistent elevation of antibody levels were noted in any of the CHB risk pregnancies. Ro52 IgG1 antibody levels were significantly higher than IgG2 (P < 0.01), IgG3 (P < 0.01) and IgG4 (P < 0.05) levels in the mothers during pregnancy. Ro52 IgG1 and IgG4 levels decreased significantly from early to late pregnancy (P = 0.02), while levels of IgG2 and IgG3 were low and the decrease was not significant. All IgG subclasses were transferred to the children. We conclude that maternal levels of Ro52, Ro60 and La autoantibodies tended rather to decrease than to increase during pregnancy.

Keywords

autoantibodies congenital heart block La Ro52 Ro60

Get full access to this article

View all access options for this article.

References

Buyon JP , Hiebert R , Copel J et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry . J Am Coll Cardiol 1998; 31: 1658-1666 .

Brucato A , Frassi M , Franceschini F et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women . Arthritis Rheum 2001; 44: 1832-1835 .

Waltuck J , Buyon JP. Autoantibody-associated congenital heart block: outcome in mothers and children . Ann Intern Med 1994; 120: 544-551 .

Julkunen H , Eronen M. The rate of recurrence of isolated congenital heart block: a population-based study . Arthritis Rheum 2001; 44: 487-488 .

Solomon DG , Rupel A , Buyon JP. Birth order, gender and recurrence rate in autoantibody-associated congenital heart block: implications for pathogenesis and family counseling . Lupus 2003; 12: 646-647 .

Eronen M , Siren MK , Ekblad H et al. Short- and long-term outcome of children with congenital complete heart block diagnosed in utero or as a newborn . Pediatrics 2000; 106: 86-91 .

Salomonsson S , Dorner T , Theander E et al. A serologic marker for fetal risk of congenital heart block . Arthritis Rheum 2002; 46: 1233-1241 .

Salomonsson S , Ottosson L , Safsten P et al. Cloning and characterization of two human Ro52-specific monoclonal autoantibodies directed towards a domain associated with congenital heart block . J Autoimmun 2004; 22: 167-177 .

Salomonsson S , Sonesson SE , Ottosson L et al. Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block . J Exp Med 2005; 201: 11-17 .

10.

Garcia S , Nascimento JH , Bonfa E et al. Cellular mechanism of the conduction abnormalities induced by serum from anti-Ro/SSA-positive patients in rabbit hearts . J Clin Invest 1994; 93: 718-724 .

11.

Boutjdir M , Chen L , Zhang ZH et al. Arrhythmogenicity of IgG and anti-52-kD SSA/Ro affinity-purified antibodies from mothers of children with congenital heart block . Circ Res 1997; 80: 354-362 .

12.

Dörner T , Chaoui R , Feist E et al. Significantly increased maternal and fetal IgG autoantibody levels to 52 kD Ro (SS-A) and La(SS-B) in complete congenital heart block . J Autoimmun 1995; 8: 675-684 .

13.

Sonesson SE , Salomonsson S , Jacobson L-A , Bremme K , Wahren-Herlenius M. Signs of first degree heart block occurs in one third of fetuses of pregnant women with anti-SSA/Ro52 antibodies . Arthritis and Rheumatism 2004; 50: 1253-1261 .

14.

Wahren M , Tengnér P , Gunnarsson I et al. Autoantibody levels to Ro/SS A and La/SS-B in patients with systemic lupus erythematosus and Sjögren’s syndrome . J Autoimmun 1998; 11: 29-38 .

15.

St Clair EW , Burch JA Jr , Ward MM , Keene JD , Pisetsky DS. Temporal correlation of antibody responses to different epitopes of the human La autoantigen . J Clin Invest 1990; 85: 515-521 .

16.

Meilof JF , Veldhoven CH , Swaak AJ , Smeenk RJ. Production of anti-Ro/SS-A and anti-La/SS-B autoantibodies is closely coordinated in systemic lupus erythematosus and independent of anti-dsDNA production . J Autoimmun 1997; 10: 67-75 .

17.

Praprotnik S , Bozic B , Kveder T , Rozman B. Fluctuation of anti-Ro/SS A antibody levels in patients with systemic lupus erythematosus and Sjogren’s syndrome: a prospective study . Clin Exp Rheumatol 1999; 17: 63-68 .

18.

Vitali C , Bombardieri S , Jonsson R et al. Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group . Ann Rheum Dis 2002; 61: 554-558 .

19.

Tan EM , Cohen AS , Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum 1982; 25: 1271-1277 .

20.

Alarcon-Segovia D , Cardiel MH. Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients . J Rheumatol 1989; 16: 328-334 .

21.

Wilson WA , Gharavi AE , Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop . Arthritis Rheum 1999; 42: 1309-1311 .

22.

Elagib KEE , Tengnér P , Levi M et al. Immunoglobulin variable genes and epitope recognition of human monoclonal anti-Ro 52-kd in primary Sjögren’s syndrome . Arthritis Rheum 1999; 42: 2471-2478 .

23.

Hinkula J , Ball JM , Löfgren S , Estes M , Svensson L. Antibody prevalence and immunoglobulin IgG subclass pattern to Norwalk virus in Sweden . J Med Virol 1995; 47: 52-57 .

24.

Sundqvist V-A , Linde A , Kurth R et al. Restriced IgG subclass responses to HTLV-III/LAV and to cytomegalovirus in patients with AIDS and lymphadenopathy syndrome . J Inf Dis 1986; 153: 970-973 .

25.

Khirwadkar MA , Kher JR. Study of serum immunoglobulins in normal pregnancy . Indian J Physiol Pharmacol 1991; 35: 69-70 .

26.

Amino N , Tanizawa O , Miyai K et al. Changes of serum immunoglobulins IgG, IgA, IgM, and IgE during pregnancy . Obstet Gynecol 1978; 52: 415-420 .

27.

Ailus K. A follow-up study of immunolglobulin levels and autoantibodies in an unselected pregnant population . Am J Reprod Immunol 1994; 31: 189-196 .

28.

Marolis GB , Buckley RH , Younger JB. Serum immunogbulin cocentrations during normal pregnancy . Am J Obstet Gynecol 1971; 109: 971-976 .

29.

Thellin O , Heinen E. Pregnancy and the immune system: between tolerance and rejection . Toxicology 2003; 185: 179-184 .

30.

Derksen RH , Meilof JF. Anti-Ro/SS-A and anti-La/SS-B autoantibody levels in relation to systemic lupus erythematosus disease activity and congenital heart block. A longitudinal study comprising two consecutive pregnancies in a patient with systemic lupus erythematosus . Arthritis Rheum 1992; 35: 953-959 .

31.

Lieu T-S , Reimer CB , Sontheimer RD. Immunoglobulin class and subclass profile of the Ro/SS-A autoantibody response . J Invest Dermatol 1988; 90: 158-164 .

32.

Elenitsas R , Abell E , Lee Y-Y , Huang J , Deng J-S. Comparision of IgG subclass antibodies in patients with systemic lupus erythematosus and aubacute lupus erythematosus . J Dermatol Sci 1990; 1: 207-216 .

33.

Pearce DC , Yount WJ , Eisenberg RA. Subclass restriction of anti-SS-B (La) autoantibodies . Clin Immunol Immunopathol 1986; 38: 111-119 .

34.

Wahren M , Ringertz NR , Pettersson I. IgM and IgG subclass distribution of human anti-Ro/SSA 60 kDa autoantibodies . Scand J Immunol 1994; 39: 179-183 .

35.

Simister NE. Placental transport of immunoglobulin G . Vaccine 2003; 21: 3365-3369 .

36.

Tseng CE , Caldwell K , Feit S , Chan EK , Buyon JP. Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block . J Rheumatol 1996; 23: 925-932 .

37.

Kaaja R , Julkunen H. Prevention of reocurrence of congential heart block with intravenous immunoglobulin and corticosteroid therapy . Arthritis Rheum 2003; 48: 280-281 .

38.

Tran HB , Cavill D , Buyon JP , Gordon TP. Intravenous immunoglobulin and placental transport of anti-Ro/La antibodies . Arthritis Rheum 2004; 50: 337-338 .